Abstract

Invasive aspergillosis is recognized as one of the most significant opportunistic infections after liver transplantation. Diagnosis of invasive aspergillosis in transplant recipients has been proven to be challenging, and optimal approach to the treatment of invasive aspergillosis is still controversial. We here present an unusual case of Aspergillus tracheobronchitis in the setting of liver transplantation. A 47-year-old female patient with persistent dry cough after liver transplantation developed respiratory insufficiency and was readmitted to the intensive care unit 55 days after liver transplantation. A CT scan revealed subtotal tracheal stenosis; bronchoscopy was performed, and extended white mucus coverings causative of the tracheal stenosis were removed. Microbiological assessment isolated Aspergillus fumigatus. The diagnosis was obstructive Aspergillus tracheobronchitis. The patient was started on a treatment of voriconazole 200 mg orally twice daily, adjusted to a trough level of 1–4 mg/L. For further airway management, a tracheal stent had to be implanted. The patient is alive and well 28 months after liver transplantation. Invasive aspergillosis should be considered a possible etiology in liver transplant patients presenting with unspecific symptoms such as persistent dry cough. Optimal strategies for improved and early diagnosis as well as prophylaxis need to be defined.

Highlights

  • Invasive aspergillosis is one of the most significant opportunistic infections in solid-organ transplant recipients, and its diagnosis carries a high mortality rate [1]

  • We describe here the case of a 47-year-old female patient suffering from persistent dry cough 40 days after liver transplantation

  • This is the first report of Aspergillus tracheobronchitis in a liver transplant recipient, random cases of Aspergillus tracheobronchitis in thoracic organ recipients and hematopoietic stem cell recipients have previously been reported

Read more

Summary

Introduction

Invasive aspergillosis is one of the most significant opportunistic infections in solid-organ transplant recipients, and its diagnosis carries a high mortality rate [1]. Approximately 45% were solid-organ transplant recipients with a median time between transplantation and symptom onset of three months. We describe here the case of a 47-year-old female patient suffering from persistent dry cough 40 days after liver transplantation. To our knowledge, this is the first report of Aspergillus tracheobronchitis in a liver transplant recipient, random cases of Aspergillus tracheobronchitis in thoracic organ recipients and hematopoietic stem cell recipients have previously been reported

Case Reports in Transplantation
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call